Two of Owensboro’s leading healthcare facilities have once again teamed up to bring an important clinical trial to the region. Pedia Research and Owensboro Dermatology are now conducting a clinical trial on actinic keratosis (A.K.) Commonly referred to as solar keratosis, A.K. is a skin condition where rough, scaly patches may be found on the skin of your face, lips, ears, back of your hands, forearms, scalp or neck. The major cause of A.K. is long-term exposure to the sun. Actinic keratosis can be a serious condition. Up to 5% of cases develop into skin cancer. Board certified dermatologist Dr. Artis P. Truett III is leading this research study. With a combined 43 years experience in dermatology, Dr. Truett and his team at Owensboro Dermatology continue to be the area’s leading dermatology specialists. This research study involves completing 5 outpatient visits over a period of 24 weeks. Participants must be age 18 or older. There is no cost for the study and medical insurance is not required. The study medication is a topical cream for the possible treatment of A.K. Qualified study participants may receive at no cost: study-related exams, investigational study medication, and compensation for time and travel. If you have any questions or would like more information about the study, please call Pedia Research at 270-685-4589. You may also visit the Pedia Research website at www.pediaresearch.com or the Owensboro Dermatology website at www.OwensboroDerm.com.
No comments:
Post a Comment